Ribomic Inc. (TYO:4591)
Japan
· Delayed Price · Currency is JPY 91.00
0.00 (0.00%)
Jun 16, 2025, 3:30 PM JST
Ribomic Revenue
In the fiscal year ending March 31, 2025, Ribomic had annual revenue of 2.11M JPY.
Revenue
2.11M
Revenue Growth
n/a
P/S Ratio
1,925.82
Revenue / Employee
n/a
Employees
24
Market Cap
4.06B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |